Drugs / G-CSF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00806598 | May 2005 → Jun 2012 | aplastic anemia, myelodysplastic syndrome | M.D. Anderson Cancer Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | “Drug: G-CSF” NCT00806598 ↗ |
| Modality | Protein / enzyme biologic | “G-CSF is a growth factor that helps raise the white cell count after receiving chemotherapy.” NCT00806598 ↗ |
| Route | Subcutaneous | “You will receive G-CSF as an injection under the skin for 3 months (or longer) once a day at the discretion of the treating physician” NCT00806598 ↗ |